EXUMA BIOTECH CORP has a total of 12 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are SHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD, FELDAN BIO INC and KSQ THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Frost Gregory Ian | 12 |
#2 | Onuffer James Joseph | 12 |
#3 | Haerizadeh Farzad | 9 |
#4 | Kundu Anirban | 6 |
#5 | Guibinga Ghiabe H | 6 |
#6 | Vigant Frederic | 5 |
Publication | Filing date | Title |
---|---|---|
US2021107949A1 | Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of mpl | |
WO2021042072A1 | Methods and compositions for the modification and delivery of lymphocytes | |
US2020255864A1 | Methods and compositions for genetically modifying and expanding lymphocytes and regulating the activity thereof | |
WO2020047527A2 | Methods and compositions for genetically modifying lymphocytes in blood or in enriched pbmcs | |
CA3111084A1 | Methods and compositions for genetically modifying lymphocytes in blood or in enriched pbmcs | |
EP3735460A1 | Methods and compositions for genetically modifying and expanding lymphocytes and regulating the activity thereof | |
US2020397821A1 | Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereof |